A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa

2001 ◽  
Vol 125 (3) ◽  
pp. 0253-0260
Author(s):  
Berrylin J. Ferguson ◽  
Suchitra Paramaesvaran ◽  
Elaine Rubinstein
2001 ◽  
Vol 125 (3) ◽  
pp. 253-260 ◽  
Author(s):  
Berrylin J. Ferguson ◽  
Suchitra Paramaesvaran ◽  
Elaine Rubinstein

1997 ◽  
Vol 11 (6) ◽  
pp. 435-442 ◽  
Author(s):  
Irakly Sulakvelidze ◽  
Mary Conway ◽  
Susan Evans ◽  
Paul I. Stetsko ◽  
Veljko Djuric ◽  
...  

Ten patients with perennial allergic rhinitis and 10 healthy subjects were studied to determine most discriminative nasal irrigation fluid marker(s) and to compare samples that were collected at baseline and over a 1-hour period, every 15 minutes. The latter were pooled and designated 1-hour sample. In the nasal irrigation we investigated the following inflammatory cells and soluble mediators: eosinophils, neutrophils, granulocyte-macrophage colony-stimulating factor, interleukin-4, interleukin-6, interleukin-8, ECP, EPX, MPO, leukotriene C4, leukotriene B4, prostaglandin E2, tryptase and fibrinogen. Patients with PAR were then treated for 2 weeks with the topical nasal steroid. The only marker that discriminated patients with perennial allergic rhinitis and healthy subjects was eosinophil count (EO%): correspondingly 14.01 ± 5.8 and 0.18 ± 0.09, (M ± SD). Difference between the studied groups did not depend on the time of irrigation, baseline or 1-hour. EO% was also the only marker of a clinically successful treatment with the nasal steroid, 14.01 ± 5.8 and 0.87 ± 0.4, before and after treatment respectively. We conclude that EO% is the most sensitive inflammatory marker of perennial allergic rhinitis, and that baseline nasal irrigation can be used to study nasal mucosal inflammation.


Allergy ◽  
2003 ◽  
Vol 58 (5) ◽  
pp. 380-385 ◽  
Author(s):  
K. Hughes ◽  
C. Glass ◽  
M. Ripchinski ◽  
F. Gurevich ◽  
T. E. Weaver ◽  
...  

2016 ◽  
Vol 18 (3) ◽  
pp. 100-103
Author(s):  
T.G. Malanicheva ◽  
◽  
N.V. Ziatdinova ◽  
L.F. Akhmadieva ◽  
◽  
...  

ORL ◽  
2021 ◽  
pp. 1-6
Author(s):  
Giancarlo Pecorari ◽  
Giuseppe Riva ◽  
Claudia Bartoli ◽  
Mattia Ravera ◽  
Valeria Dell’Era ◽  
...  

Introduction: Radiofrequency turbinate volume reduction (RFTVR) is an effective treatment of inferior turbinate hypertrophy. RFTVR can reduce epithelial cell alterations in nasal mucosa. The aim of this observational study was to evaluate the effects of RFTVR on nasal obstruction and cytology, stratifying for different types of rhinitis. Methods: Nasal cytology and subjective nasal obstruction were evaluated on 113 patients before RFTVR (T0) and after 3 months (T1). The patients were divided into groups on the basis of the underlying disease: allergic rhinitis, nonallergic rhinitis, rhinitis medicamentosa, and other diseases (e.g., hormonal-based turbinate hypertrophy). Results: Nasal cytology at T0 identified 42 patients with allergic rhinitis, 40 with nonallergic rhinitis, 19 with rhinitis medicamentosa, and 12 with other diseases. An improvement of nasal cytology at T1 was observed in 29.2% of cases. They mainly consisted of patients with nonallergic rhinitis with neutrophils, whose neutrophil infiltrate decreased. Only 2 cases (1.7%) showed a worsening of nasal cytology at T1. A statistically significant decrease in subjective nasal obstruction was observed for every group (p < 0.05). Higher differences of nasal obstruction between T0 and T1 were found in patients with rhinitis medicamentosa or other diseases. Conclusion: RFTVR represents a safe and effective treatment for turbinate hypertrophy of various etiology. It is not responsible for a worsening of inflammatory infiltrate of the nasal mucosa.


Sign in / Sign up

Export Citation Format

Share Document